Hello, everyone, and welcome to the working week. We hope the weekend was refreshing. Now, of course, the time has come to resume the routine of meetings and deadlines. To cope - yes - we are brewing the mandatory cup of stimulation. After all, this is Monday morning. And we know you can relate. So please join us. Meanwhile, here are some tidbits. Have a good one and stay in touch...
US Supreme Court Declines To Hear Lilly Gemzar Patent Case (Bloomberg News)
EMA Board Fails To Agree On A New CEO (Financial Times)
Teva Buys Majority Stake In Japan's Taiyo Pharma (Bloomberg News)
Is Elan A Takeover Target? (The Irish Independent)
Florida Man Sues Merck Over Propecia And Loss Of Sex Life (Lakeland Ledger)
Sanofi Signs Crohn's Disease Pact With Glenmark (Pharma Times)
Glaxo To Reveal Prices Charged To UNICEF (The Telegraph)
FDA Panel To Review Acetaminophen Dosing For Children (Dow Jones)
US Smallpox Antiviral Contract Delayed By Protest (InPharma Technologist)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr
1 Comment
Just give the Lakeland dude a lifetime supply of Vitamin V and be done with it.